Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Saunders-Pullman

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Endocrine|June 5, 2003
Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?Rachel Saunders-Pullman
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2014
The complexities of hormonal influences and risk of Parkinson's diseaseConnie Marras, Rachel Saunders-Pullman
The New England Journal of Medicine|January 24, 2019
When to Start Levodopa Therapy for Parkinson's DiseaseSusan Bressman, Rachel Saunders-Pullman
Current Neurology and Neuroscience Reports|July 2, 2013
The association between ß-glucocerebrosidase mutations and parkinsonismMatthew Swan, Rachel Saunders-Pullman
Muscle & Nerve|December 12, 2013
Atypical presentation of late-onset Tay-Sachs diseaseAndres Deik, Rachel Saunders-Pullman
Current Drug Abuse Reviews|May 7, 2010
Substance abuse and movement disordersMarta San Luciano, Rachel Saunders-Pullman
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Primary dystonia: moribund or viableSusan B Bressman, Rachel Saunders-Pullman
Addiction Biology|June 28, 2006
Movement disorders and alcohol misuseChristopher W Hess, Rachel Saunders-Pullman
Advances in Neurology|April 24, 2002
Inherited myoclonus-dystoniaRachel Saunders-Pullman, Laurie Ozelius, Susan B Bressman
Current Drug Abuse Reviews|October 4, 2012
Substance of abuse and movement disorders: complex interactions and comorbiditiesAndres Deik, Rachel Saunders-Pullman, Marta San Luciano
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Endocrine|June 5, 2003
Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?Rachel Saunders-Pullman
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2014
The complexities of hormonal influences and risk of Parkinson's diseaseConnie Marras, Rachel Saunders-Pullman
The New England Journal of Medicine|January 24, 2019
When to Start Levodopa Therapy for Parkinson's DiseaseSusan Bressman, Rachel Saunders-Pullman
Current Neurology and Neuroscience Reports|July 2, 2013
The association between ß-glucocerebrosidase mutations and parkinsonismMatthew Swan, Rachel Saunders-Pullman
Muscle & Nerve|December 12, 2013
Atypical presentation of late-onset Tay-Sachs diseaseAndres Deik, Rachel Saunders-Pullman
Current Drug Abuse Reviews|May 7, 2010
Substance abuse and movement disordersMarta San Luciano, Rachel Saunders-Pullman
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Primary dystonia: moribund or viableSusan B Bressman, Rachel Saunders-Pullman
Addiction Biology|June 28, 2006
Movement disorders and alcohol misuseChristopher W Hess, Rachel Saunders-Pullman
Advances in Neurology|April 24, 2002
Inherited myoclonus-dystoniaRachel Saunders-Pullman, Laurie Ozelius, Susan B Bressman
Current Drug Abuse Reviews|October 4, 2012
Substance of abuse and movement disorders: complex interactions and comorbiditiesAndres Deik, Rachel Saunders-Pullman, Marta San Luciano
Pageof 14